Last reviewed · How we verify
betamethasone + gentamicin + tolnaftato + cleoquinol
betamethasone + gentamicin + tolnaftato + cleoquinol is a steroid Small molecule drug developed by EMS. It is currently in Phase 3 development for skin infections, wound infections.
Betamethasone is a corticosteroid that reduces inflammation, gentamicin is an antibiotic that kills bacteria, tolnaftate is an antifungal that inhibits fungal growth, and cleocinol is an antibiotic that inhibits bacterial cell wall synthesis.
Betamethasone is a corticosteroid that reduces inflammation, gentamicin is an antibiotic that kills bacteria, tolnaftate is an antifungal that inhibits fungal growth, and cleocinol is an antibiotic that inhibits bacterial cell wall synthesis. Used for skin infections, wound infections.
At a glance
| Generic name | betamethasone + gentamicin + tolnaftato + cleoquinol |
|---|---|
| Sponsor | EMS |
| Drug class | steroid |
| Modality | Small molecule |
| Therapeutic area | infectious disease |
| Phase | Phase 3 |
Mechanism of action
Betamethasone works by binding to glucocorticoid receptors, which reduces the production of pro-inflammatory cytokines. Gentamicin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing bacteria. Tolnaftate works by inhibiting the enzyme squalene epoxidase, which is necessary for fungal cell wall synthesis. Cleocinol works by binding to the bacterial cell wall, inhibiting cell wall synthesis and ultimately killing bacteria.
Approved indications
- skin infections
- wound infections
Common side effects
- hypersensitivity reactions
- nausea
- vomiting
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- betamethasone + gentamicin + tolnaftato + cleoquinol CI brief — competitive landscape report
- betamethasone + gentamicin + tolnaftato + cleoquinol updates RSS · CI watch RSS
- EMS portfolio CI
Frequently asked questions about betamethasone + gentamicin + tolnaftato + cleoquinol
What is betamethasone + gentamicin + tolnaftato + cleoquinol?
How does betamethasone + gentamicin + tolnaftato + cleoquinol work?
What is betamethasone + gentamicin + tolnaftato + cleoquinol used for?
Who makes betamethasone + gentamicin + tolnaftato + cleoquinol?
What drug class is betamethasone + gentamicin + tolnaftato + cleoquinol in?
What development phase is betamethasone + gentamicin + tolnaftato + cleoquinol in?
What are the side effects of betamethasone + gentamicin + tolnaftato + cleoquinol?
Related
- Drug class: All steroid drugs
- Manufacturer: EMS — full pipeline
- Therapeutic area: All drugs in infectious disease
- Indication: Drugs for skin infections
- Indication: Drugs for wound infections
- Compare: betamethasone + gentamicin + tolnaftato + cleoquinol vs similar drugs
- Pricing: betamethasone + gentamicin + tolnaftato + cleoquinol cost, discount & access